Throughout the year, the Company reported significant positive preclinical findings for SIL204 across eight KRAS mutations and four cancer types, including first evidence of activity in gastric cancer ...
As we approach the close of the first quarter of 2026, our Labor, Employment & OSHA team highlights some of the leading legal developments and issues that employers face, including the reshaping of ...
Total revenue of $41.8 million in Q4 2025, up 86% as reported and 23% on an adjusted pro forma basis versus Q4 2024Greenbrook clinic revenue of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results